Global /South Korea /Healthcare /Drug Manufacturers - General /018620

WooGene B&G Co., Ltd.

018620

• KRX: 018620 • Delayed

3,730KRW 0%

2.44 USD

As of 13 June 2026, WooGene B&G Co., Ltd. has a market cap of $14.17M USD, ranking #39319 globally and #2488 in South Korea. It ranks #3502 in the Healthcare sector, and #1146 in the Drug Manufacturers - General industry.

Global Rank

39319

Country Rank

2488

Sector Rank

3502

Industry Rank

1146

Key Stats

Market Cap

$14.17MUSD

21.55B KRW

Enterprise Value

$46.14MUSD

70.41B KRW

Revenue (TTM)

$36.01MUSD

54.76B KRW

EBITDA (TTM)

$2.95MUSD

4.5B KRW

Net Income (TTM)

-$1.17MUSD

-1.77B KRW

EBITDA Margin

8.2%

Profit Margin

-3.2%

PS Ratio

0.4

PB Ratio

0.3

EV/EBITDA

11.5

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Seokjin Kang open_in_new

Employees

Founded

1977

Website

woogenebng.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	-1.7%	9.5%	-6%	-15%	-10%	-17%	-50%	-75%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	018620 우진비앤지(주) ISIN: KR7018620005 Shares Out.: Shares Outstanding: 5.777M¹ Shares Float: 4.318M² TV: TradingView: KRX: 018620 SA: Stock Analysis: KRX: 018620 YF: Yahoo Finance: 018620.KS GF: Google Finance: KRX: 018620 BA: Barron's: 018620 MS: Morningstar: XKRX: 018620	3,730 KRW	TV: TradingView: KRX: 018620 SA: Stock Analysis: KRX: 018620 YF: Yahoo Finance: 018620.KS GF: Google Finance: KRX: 018620 BA: Barron's: 018620 MS: Morningstar: XKRX: 018620

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About WooGene B&G Co., Ltd.

WooGene B&G Co., Ltd. engages veterinary medicines, microbial technology, and vaccines business in South Korea and internationally. It offers antibiotic, vaccine, nutrient, anti-inflammation, metabolic stimulant, and iron supplement products for swine, poultry, cattle, aquatic animals, companion animals, and raw materials, as well as operates vaccine research center. The company was formerly known as WooJin Co., Ltd. and changed its name to WooGene B&G Co., Ltd. in March 2001. WooGene B&G Co., Ltd. was founded in 1977 and is headquartered in Hwaseong-si, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.15B 13.91T KRW 64K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.77B 10.3T KRW 48K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.24B 7.97T KRW 37K%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$4.96B 7.55T KRW 35K%	-	South Korea
Yuhan Corp. KRX: 000100	$4.55B 6.92T KRW 32K%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.44B 6.76T KRW 31K%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 5M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 4M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 3M%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 2M%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 2M%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 2M%	20.5	Switzerland

chevron_leftBack